Connect with us

Technology

Tecsys Reports Record Revenue for the Fourth Quarter and Full Year Fiscal 2024

Published

on

SaaS subscription bookings set new record in fourth quarter, SaaS RPO climbs 43%

MONTREAL, June 27, 2024 /CNW/ — Tecsys Inc. (TSX: TCS), an industry-leading supply chain management SaaS company, today announced its results for the fourth quarter and full year of fiscal 2024, ended April 30, 2024. All dollar amounts are expressed in Canadian currency and are prepared in accordance with International Financial Reporting Standards (IFRS).

“Fiscal 2024 has been a landmark year for Tecsys in which we have demonstrated our ability to drive continued growth and expand market opportunity,” said Peter Brereton, president and CEO at Tecsys. “Our SaaS revenue surged by 39% in fiscal 2024 and we achieved record-breaking SaaS bookings in our fourth quarter as well as for the full year. We head into fiscal 2025 with confidence that we are delivering exceptional value to our customers and are well-positioned to capitalize on our market momentum.”

Mark Bentler, chief financial officer of Tecsys Inc., added, “Our financial performance in fiscal 2024 underscores the strength of our business model. With a 43% increase in SaaS RPO in fiscal 2024 and positive evolution in our gross margin profiles, we continue to see the path for AEBITDA margin expansion to 8-9% in fiscal 2025 and 10-11% in fiscal 2026.”

Fourth Quarter Highlights:

SaaS revenue increased by 27% to $14.2 million, up from $11.1 million in Q4 2023.SaaS subscription bookingsi (measured on an ARRi basis) increased by 108% to a record $8.0 million, compared to $3.9 million in the fourth quarter of fiscal 2023.SaaS Remaining Performance Obligation (RPOi) increased by 43% to $196.9 million at April 30, 2024, up from $137.7 million at the same time last year.Annual Recurring Revenue (ARRi) at April 30, 2024 was up 21% to $94.7 million compared to $78.3 million at April 30, 2023.Total revenue increased 7% to a record $44.0 million compared to $41.2 million in Q4 2023. Professional services revenue decreased by 2% to $14.4 million compared to $14.6 million in Q4 2023.Gross margin was 47% for the fourth quarter of fiscal 2024 compared to 45% for the same period in fiscal 2023.Total gross profit increased to $20.6 million, up 12% from $18.4 million in Q4 2023.Operating expenses increased to $21.3 million, higher by $4.3 million or 25% compared to $17.0 million in Q4 last year. Q4 2024 operating expenses included $2.1 million of restructuring costs.Loss from operations (including the impact of restructuring costs) was $0.6 million in Q4 2024, compared to a profit from operations of $1.4 million in Q4 2023.Net profit was $0.3 million or $0.02 per share on a fully diluted basis in Q4 2024, compared to $0.4 million or $0.03 per share for the same period in fiscal 2023.Adjusted EBITDAii was $2.8 million, up 14% compared to $2.4 million reported in Q4 last year.In the fourth quarter of fiscal 2024, Tecsys acquired 128,300 of its outstanding common shares for approximately $5.0 million as part of its ongoing normal course issuer bid.

Fiscal 2024 Highlights:

SaaS revenue increased by 39% to $51.9 million, up from $37.5 million in fiscal 2023.SaaS subscription bookingsi (measured on an ARRi basis) increased to $18.6 million, up 13% from $16.4 million in fiscal 2023.Total revenue increased 12% to $171.2 million compared to $152.4 million in fiscal 2023.Professional services revenue was $55.2 million, down slightly compared to $55.4 million in fiscal 2023.Gross margin was 46% for fiscal 2024 compared to 44% for fiscal 2023.Total gross profit increased to $78.4 million, up 17% from $66.8 million in the same period of fiscal 2023.Operating expenses increased to $76.5 million, higher by $13.2 million or 21% compared to $63.2 million in fiscal 2023.Profit from operations (including the impact of restructuring) was $1.9 million, down from $3.6 million in fiscal 2023.Net profit was $1.8 million, or $0.13 per diluted share in fiscal 2024, compared to a net profit of $2.1 million, or $0.14 per diluted share, for fiscal 2023.Adjusted EBITDAii was $9.6 million, up slightly compared to $9.5 million in fiscal 2023.

Financial Guidance:

Tecsys is providing financial guidance as follows:

FY25 Guidance

FY26 Guidance

Total Revenue Growth

7-9%

n.a.

SaaS Revenue Growth

30-32%

n.a.

Adjusted EBITDAii Margin

8-9%

10-11%

 

On June 27, 2024, the Company declared a quarterly dividend of $0.08 per share to be paid on August 2, 2024 to shareholders of record on July 12, 2024.

Pursuant to the Canadian Income Tax Act, dividends paid by the Company to Canadian residents are considered to be “eligible” dividends.

Q4 and FY2024 Financial Results Conference Call
Date: June 28, 2024
Time: 8:30 a.m. ET
Phone number: 800-836-8184 or 646-357-8785
The call can be replayed until July 5, 2024, by calling:
888-660-6345 or 646-517-4150 (access code: 46999#)

i See Key Performance Indicators in Management’s Discussion and Analysis of the 2024 Financial Statements.

ii See Non-IFRS Performance Measures in Management’s Discussion and Analysis of the 2024 Financial Statements.

About Tecsys

Tecsys is a global provider of advanced supply chain solutions. With a commitment to innovation and customer success, the company equips organizations with the essential software, technology and expertise needed for operational excellence and competitive advantage. Its cloud solutions serve a diverse range of industries, including healthcare, distribution and converging commerce, across multiple complex, regulated and high-volume markets. Built on the Itopia® low-code application platform, Tecsys’ offerings include enterprise resource planning, warehouse management, consolidated service management, distribution and transportation management, supply management at the point of use and order management solutions. Tecsys provides critical data insights and control across the supply chain, ensuring that organizations are agile, responsive and scalable. Tecsys is publicly traded on the Toronto Stock Exchange under the ticker symbol TCS. For more about Tecsys and its solutions, please visit www.tecsys.com.

Forward Looking Statements
The statements in this news release relating to matters that are not historical fact are forward-looking statements that are based on management’s beliefs and assumptions. Such statements are not guarantees of future performance and are subject to a number of uncertainties, including but not limited to future economic conditions, the markets that Tecsys Inc. serves, the actions of competitors, major new technological trends, and other factors beyond the control of Tecsys Inc., which could cause actual results to differ materially from such statements. More information about the risks and uncertainties associated with Tecsys Inc.’s business can be found in the MD&A section of the Company’s annual report and the most recently filed annual information form. These documents have been filed with the Canadian securities commissions and are available on our website (www.tecsys.com) and on SEDAR+ (www.sedarplus.ca).

Copyright © Tecsys Inc. 2024. All names, trademarks, products, and services mentioned are registered or unregistered trademarks of their respective owners.

Non-IFRS Measures

Reconciliation of EBITDA and Adjusted EBITDA

EBITDA is calculated as earnings before interest expense, interest income, income taxes, depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before stock-based compensation, gain on remeasurement of lease liability, recognition of tax credits generated in prior periods and restructuring costs. The exclusion of interest expense, interest income, income taxes and restructuring costs eliminates the impact on earnings derived from non-operational activities and non-recurring items, and the exclusion of depreciation, amortization, stock-based compensation, gain on remeasurement of lease liability and recognition of tax credits generated in prior periods eliminates the non-cash impact of these items. 

The Company believes that these measures are useful measures of financial performance without the variation caused by the impacts of the items described above and that could potentially distort the analysis of trends in our operating performance. In addition, they are commonly used by investors and analysts to measure a company’s performance, its ability to service debt and to meet other payment obligations, or as a common valuation measurement. Excluding these items does not imply that they are necessarily non-recurring. Management believes these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, enable investors to evaluate the Company’s operating results, underlying performance and future prospects in a manner similar to management. Although EBITDA and Adjusted EBITDA are frequently used by securities analysts, lenders and others in their evaluation of companies, they have limitations as an analytical tool, and should not be considered in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS.

The reconciliation of EBITDA and Adjusted EBITDA to the most directly comparable IFRS measure is provided below.

Year ended April 30,

(in thousands of CAD)

2024

2023

2022

Net profit for the period

$

1,849

$

2,089

$

4,478

Adjustments for:

Depreciation of property and equipment and right-of-use assets

1,477

1,775

2,162

Amortization of deferred development costs

583

496

290

Amortization of other intangible assets

1,493

1,603

1,612

Interest expense

163

406

622

Interest income

(1,015)

(686)

(474)

Income taxes

641

1,624

946

EBITDA

$

5,191

$

7,307

$

9,636

Adjustments for:

Stock based compensation

2,301

2,177

1,684

Gain on remeasurement of lease liability

(573)

Recognition of tax credits generated in prior periods

(617)

Restructuring costs

2,122

Adjusted EBITDAii

$

9,614

$

9,484

$

10,130

 

Consolidated Statements of Financial Position
(In thousands of Canadian dollars)

April 30, 2024

April 30, 2023

Assets

Current assets

Cash and cash equivalents

$

18,856

$

21,235

Short-term investments

16,713

15,835

Accounts receivable

22,090

22,900

Work in progress

4,248

1,734

Other receivables

134

523

Tax credits

6,422

5,338

Inventory

1,359

1,034

Prepaid expenses and other

9,143

8,193

Total current assets

78,965

76,792

 

Non-current assets

Other long-term receivables and assets

421

363

Tax credits

4,737

5,368

Property and equipment

1,372

1,802

Right-of-use assets

1,251

1,708

Contract acquisition costs

4,478

3,738

Deferred development costs

2,683

2,254

Other intangible assets

7,703

9,287

Goodwill

17,363

17,467

Deferred tax assets

9,073

8,137

Total non-current assets

49,081

50,124

Total assets

$

128,046

$

126,916

Liabilities

Current liabilities

Accounts payable and accrued liabilities

20,030

21,669

Deferred revenue

36,211

30,388

Lease obligations

812

793

Total current liabilities

57,053

52,850

 

Non-current liabilities

Other long-term accrued liabilities

496

253

Deferred tax liabilities

826

1,255

Lease obligations

1,302

2,120

Total non-current liabilities

2,624

3,628

Total liabilities

$

59,677

$

56,478

 

Equity

Share capital

$

52,256

$

44,338

Contributed surplus

9,417

15,285

Retained earnings

8,121

10,832

Accumulated other comprehensive loss

(1,425)

(17)

Total equity attributable to the owners of the Company

68,369

70,438

Total liabilities and equity

$

128,046

$

126,916

 

Consolidated Statements of Income and Comprehensive (loss) Income 
(In thousands of Canadian dollars, except per share data)

Three Months Ended

Twelve Months Ended

April 30,

April 30,

2024

2023

2024

2023

Revenue:

SaaS

$

14,191

$

11,133

$

51,918

$

37,476

Maintenance and Support

8,140

7,992

33,957

32,714

Professional Services

14,390

14,614

55,188

55,353

License

282

529

1,386

3,116

Hardware

6,952

6,924

28,793

23,765

Total revenue

43,955

41,192

171,242

152,424

Cost of revenue

23,341

22,828

92,853

85,615

Gross profit

20,614

18,364

78,389

66,809

Operating expenses:

Sales and marketing

8,437

7,778

32,976

28,080

General and administration

3,264

2,599

11,844

11,218

Research and development, net of tax credits

7,435

6,597

29,514

23,943

Restructuring costs

2,122

2,122

Total operating expenses

21,258

16,974

76,456

63,241

(Loss) profit from operations

(644)

1,390

1,933

3,568

Other income (costs)

122

(189)

557

145

(Loss) profit before income taxes

(522)

1,201

2,490

3,713

Income tax (benefit) expense

(781)

755

641

1,624

Net profit

$

259

$

446

$

1,849

$

2,089

Other comprehensive income (loss):

Effective portion of changes in fair value on designated revenue hedges

(2,187)

(521)

(1,086)

(6)

Exchange differences on translation of foreign operations

102

489

(322)

1,423

Comprehensive (loss) income

$

(1,826)

$

414

$

441

$

3,506

Basic and diluted earnings per common share

$

0.02

$

0.03

$

0.13

$

0.14

 

Consolidated Statements of Cash Flows
(In thousands of Canadian dollars)

Three Months Ended

Twelve Months Ended

April 30,

April 30,

2024

2023

2024

2023

Cash flows from operating activities:

Net profit

$

259

$

446

$

1,849

$

2,089

Adjustments for:

Depreciation of property and equipment and right-of-use-assets

361

440

1,477

1,775

Amortization of deferred development costs

147

145

583

496

Amortization of other intangible assets

347

402

1,493

1,603

Interest (income) expense and foreign exchange (gain) loss

(122)

189

(557)

(145)

Unrealized foreign exchange and other

481

1,336

(569)

1,754

Non-refundable tax credits

(596)

(429)

(1,961)

(2,095)

Stock-based compensation

531

455

2,301

2,177

Income taxes

65

124

519

554

Net cash from operating activities excluding changes in non-cash
   working capital items related to operations

1,473

3,108

5,135

8,208

Accounts receivable

2,714

955

764

(5,915)

Work in progress

(856)

208

(2,518)

(151)

Other receivables and assets

(135)

163

1

(58)

Tax credits

(728)

3,239

113

(114)

Inventory

544

268

(327)

(226)

Prepaid expenses

299

21

(646)

(1,452)

Contract acquisition costs

(784)

(190)

(1,045)

(908)

Accounts payable and accrued liabilities

(3,052)

1,645

(2,455)

3,259

Deferred revenue

5,506

1,258

5,833

5,713

Changes in non-cash working capital items related to operations

3,508

7,567

(280)

148

Net cash provided by operating activities

4,981

10,675

4,855

8,356

Cash flows from financing activities:

Repayment of long-term debt

(8,400)

Proceeds from short-term investments

5,000

Payment of lease obligations

(193)

(119)

(786)

(689)

Payment of dividends

(1,175)

(1,094)

(4,560)

(4,225)

Interest paid

(27)

(17)

(163)

(406)

Issuance of common shares on exercise of stock options

3,897

185

6,964

297

Shares repurchased and cancelled

(5,010)

(7,215)

Net cash used in financing activities

(2,508)

(1,045)

(5,760)

(8,423)

Cash flows from investing activities:

Interest received

6

27

97

90

Transfers from short-term investments

40

Acquisitions of property and equipment

(144)

(340)

(599)

(850)

Acquisitions of other intangible assets

(62)

Deferred development costs

(203)

(283)

(1,012)

(880)

Net cash used in investing activities

(341)

(596)

(1,474)

(1,702)

Net Increase (decrease) in cash and cash equivalents during the period

2,132

9,034

(2,379)

(1,769)

Cash and cash equivalents – beginning of period

16,724

12,201

21,235

23,004

Cash and cash equivalents – end of period

$

18,856

$

21,235

$

18,856

$

21,235

 

Consolidated Statements of Changes in Equity
(In thousands of Canadian dollars, except number of shares)

Share capital

Number

Amount

Contributed
Surplus

Accumulated
other
comprehensive
income (loss)

Retained
earnings

Total

Balance, May 1, 2023

14,582,837

$

44,338

$

15,285

$

(17)

$

10,832

$

70,438

Net profit

1,849

1,849

Other comprehensive (loss) income:

Effective portion of changes in fair value on designated revenue hedges

(1,086)

(1,086)

Exchange difference on translation of foreign operations

(322)

(322)

Total comprehensive (loss) income

(1,408)

1,849

441

Shares repurchased and cancelled

(204,500)

(684)

(6,531)

(7,215)

Stock-based compensation

2,301

2,301

Dividends to equity owners

(4,560)

(4,560)

Share options exercised

461,813

8,602

(1,638)

6,964

Total transactions with owners of the Company

257,313

$

7,918

(5,868)

$

$

(4,560)

$

(2,510)

Balance, April 30, 2024

14,840,150

$

52,256

9,417

$

(1,425)

$

8,121

$

68,369

Balance, May 1, 2022

14,562,895

$

43,973

13,176

$

(1,434)

$

12,968

$

68,683

Net profit

2,089

2,089

Other comprehensive income:

Effective portion of changes in fair value on designated revenue hedges

(6)

(6)

Exchange difference on translation of foreign operations

1,423

1,423

Total comprehensive income

1,417

2,089

3,506

Stock-based compensation

2,177

2,177

Dividends to equity owners

(4,225)

(4,225)

Share options exercised

19,942

365

(68)

297

Total transactions with owners of the Company

19,942

$

365

2,109

$

$

(4,225)

$

(1,751)

Balance, April 30, 2023

14,582,837

$

44,338

15,285

$

(17)

$

10,832

$

70,438

 

 

SOURCE Tecsys Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Another Nine Opens First Franchise Location in North Carolina Signaling New Era of Growth

Published

on

By

Franchise Owner Matt Hess Debuts First of Five Greater Charlotte Locations as 24/7 Indoor Golf Concept Surpasses 75 Territories Sold

CINCINNATI, June 16, 2026 /PRNewswire/ — Another Nine, the 24/7 self-service indoor golf concept powered by proprietary A9OS technology and Trackman gameplay, is celebrating the opening of its first franchise location in Cornelius, North Carolina, as the brand moves from a breakout first year of franchise sales into a new phase of unit growth.

Located in the Lake Norman area, the new Cornelius facility is owned and operated by Matt Hess, Another Nine’s first franchise owner. It is the first of five locations Hess will open across the greater Charlotte area. The brand has 12 locations planned throughout the Charlotte metro, making the market the first fully sold-out region in Another Nine’s franchise network.

First Franchise Opening Anchors Charlotte Expansion

The Cornelius opening marks Another Nine’s first franchise location and gives the brand an early foothold in one of North Carolina’s most active suburban markets. With Charlotte sold out, the brand has laid the foundation for a multi-unit growth strategy built around local operators, streamlined operations, and demand for flexible, private indoor golf access.

“Cornelius was the right place to begin because Lake Norman is home for me, and the community has been supportive from the start,” said Hess. “Another Nine makes it easy for people to play on their own schedule, whether they want to practice after the kids go to bed, get in a round before work, or step into a private suite between calls. The founders have built a smart model with strong technology and real support behind it. I am proud to open the first of my five locations here and help introduce Another Nine to the Charlotte market.”

A New Era of Growth for Another Nine

The first franchise opening follows a year of momentum for Another Nine, which has surpassed 75 franchise territories sold in its inaugural year of franchising. The company currently operates two corporate locations in Cincinnati, Columbia-Tusculum, and Montgomery, and is now focused on converting its early franchise traction into open facilities across targeted growth regions.

As Another Nine continues expansion, the brand is placing a particular priority on the Midwest and Northeast, where dense suburban markets, year-round golf demand, and access to multi-unit operators align with its membership-free, technology-driven model.

“The Cornelius opening is a defining moment for Another Nine because it shows what this model can become with the right franchise partner in the right market,” said Ethan Grob, Co-Founder of Another Nine. “Matt understands the guest experience, the Charlotte community and the growth opportunity ahead. As we enter this next stage, our priority is to support owners like Matt while expanding thoughtfully in markets where golfers are looking for premium, flexible access to the game.”

A 24/7 Indoor Golf Model Built for Guests and Operators

Each Another Nine facility features all-private Sim Suites available around the clock through the brand’s A9OS booking platform. Guests can reserve a suite by the hour, any time of day or night, and play Trackman-powered golf across more than 350 world-class courses without a membership requirement.

The model is also designed to give franchise owners a streamlined operating structure. Without a bar or restaurant component and with technology supporting booking, access, and guest support, Another Nine locations are built to operate with a leaner footprint than many entertainment concepts.

Guests can expect:

Private Sim Suites available 24/7Hourly reservations with no membership requiredTrackman gameplay across more than 350 coursesProprietary A9OS technology for booking, access and supportA flexible setting for practice, casual rounds, small groups and late-night play

For more information about franchising with Another Nine, visit anothernine.com/pages/franchise.

About Another Nine

Another Nine is a franchisor of 24/7 self-service indoor golf simulator facilities featuring all-private Sim Suites and Trackman gameplay, powered by proprietary A9OS technology. With a membership-free model and a streamlined operating structure, Another Nine offers guests premium access to the game on their schedule and offers entrepreneurs a modern path to business ownership.

View original content to download multimedia:https://www.prnewswire.com/news-releases/another-nine-opens-first-franchise-location-in-north-carolina-signaling-new-era-of-growth-302801851.html

SOURCE Another Nine, LLC

Continue Reading

Technology

Personal Protective Equipment Market to Reach USD 34.22 Billion by 2031 | 3M, DuPont, Ansell, MSA, and 37 Key Players Profiled | Arizton

Published

on

By

Arizton report highlights smart PPE adoption, industrial safety trends, regional growth opportunities, competitive benchmarking, and market forecasts through 2031.

CHICAGO, June 16, 2026 /PRNewswire/ — According to recent research by Arizton, the global personal protective equipment (PPE) market is expected to reach USD 34.22 billion by 2031, growing at a CAGR of 6.54% during the forecast period.  

The market continues to gain growth as workplace safety regulations become more stringent across industries such as manufacturing, healthcare, construction, oil & gas, chemicals, and logistics. Increasing awareness of employee protection, expanding industrial activity, and stronger compliance standards are expected to continue supporting PPE demand globally.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.arizton.com/market-reports/personal-protective-equipment-market

Browse in-depth TOC on the Global Personal Protective Equipment Market

Pages- 163
Region- 5
Company- 37
Segment-5

Global Personal Protective Equipment Market Snapshot

Market Size (2031)

USD 34.22 Billion

Market Size (2025)

USD 23.40 Billion

CAGR (2025-2031)

6.54 %

Historic Year

2022-2024

Base Year

2025

Forecast Year

2026-2031

Segments Covered

Product, Protection, Application, End-User, and Geography

Smart PPE is Transforming Workplace Safety Across Industrial Environments

The growing emphasis on proactive workplace safety and real-time hazard prevention is increasing the adoption of smart PPE solutions across industrial environments.

Unlike conventional protective equipment, smart PPE integrates IoT sensors, AI-enabled analytics, and connectivity technologies such as Bluetooth, Wi-Fi, and 5G to support real-time worker monitoring, predictive alerts, and enhanced hazard detection.

According to research published by IRE Journals in February 2025, integrating smart PPE solutions can reduce workplace accidents by up to 40% and improve safety compliance by nearly 30%. Supported by increasing industrial digitalization and connected workplace initiatives, demand for smart PPE is expected to rise significantly over the forecast period.

North America Holds the Largest PPE Market Share Supported by Expanding Industrial Activity

North America accounted for over 36% of the global PPE market share, supported by strict workplace safety regulations, expanding industrial activity, and manufacturing reshoring efforts.

The region continues to witness strong demand across healthcare, construction, oil & gas, and industrial manufacturing sectors. Healthcare systems in North America have also transitioned from emergency pandemic procurement toward maintaining stable PPE inventories, creating a more consistent long-term demand base.

The U.S. remains the largest and fastest-growing regional market, supported by infrastructure investments, increasing smart PPE adoption, and domestic manufacturing expansion.

To Know More, Click: https://www.arizton.com/request-sample/5137

Hand Protection Segment Leads as Regional PPE Demand Evolves

North America: Growth is centered heavily around oil, gas, and regulatory compliance.Asia-Pacific (APAC): Demand is driven by infrastructure and commercial construction projects.Middle East & Africa (MEA): Procurement is dominated by the upstream energy and utility sectors.Global Logistics: The rising trade of temperature-sensitive biologics (like vaccines) has expanded cold-storage infrastructure, driving the demand for specialized thermal protective garments.

Recent Developments Shaping the Personal Protective Equipment Market

In March 2026, DuPont introduced a specialized disposable garment engineered for designed for cleanrooms, containment, and other high-hazard environments.In January 2026, Ansell Ltd introduced the TouchNTuff 93-800. This innovative single-use glove is engineered to provide a minimum of 15 minutes of protection against acetone exposure.In October 2025, 3M introduced the 3M PELTOR WS ALERT XPV Headset MRX21A1WS7. These solar-powered headsets provide robust communication solutions with Bluetooth® MultiPoint technology and noise-cancelling microphones.In September 2025, MSA Safety Incorporated launched the V-Gard H2 Full Brim Safety Type 2 Helmet. It provides enhanced lateral impact protection. It is designed for workers needing extra debris and sun protection.

Personal Protective Equipment Market Segmentation Highlights

Product: The disposable segment accounted for the largest market share of around 64%.Protection: The hand protection segment dominated and held the largest market share in 2025Application: The chemical protection segment shows significant growth, with the fastest-growing CAGR of 6.78%End-User: The manufacturing segment accounted for the largest market share in 2025.Geography: North America dominates the global PPE market, accounting for over 36% of the market share.

Download a FREE PDF Sample of the Report: https://www.arizton.com/request-sample/5137

List Of Key Personal Protective Equipment (PPE) Market Companies Profiles

Key Vendors

3MProtective Industrial Products, IncAnsell LimitedDuPont de Nemours, Inc.MSA Worldwide, LLC

Other Prominent Vendors

Lakeland Industries Inc.Delta Plus GroupUvex Safety GroupDragerwerk AG & Co. KGaAAlpha Pro Tech Ltd.Radians Inc.Showa GroupMoldex-MetricMallcom India Ltd.MCR SafetyAlexandraASATEX AGAvon Technologies plcBennett SafetywearCardinal HealthCOFRA S.r.l.Dynarex CorporationGateway Safety, Inc.Globus Global SafetyGore-TexJSP LtdSanctum Work Wear Pvt LtdSioenStanley Black & Decker, Inc.Superior Glove Works Ltd.WenassWurth GroupSioen IndustriesPortwestShaanxi Dursafety Materials Co.,Ltd (Dursafety)BullardSupermax Corporation Berhad (Malaysia)Brazil Safety Brands

 What Key Findings Will Our Research Analysis Reveal?

How big is the global personal protective equipment market?What is the growth rate of the global personal protective equipment market?What are the key trends in the global personal protective equipment market?Which region dominates the global personal protective equipment market?Which protection segment provides more business opportunities in the global personal protective equipment market?Who are the key vendors in the global personal protective equipment market?

About Us:                                                                                   
Arizton Advisory & Intelligence delivers data-driven market research and strategic consulting that empowers clients to make informed decisions and drive growth. Combining quantitative and qualitative insights, we provide in-depth analysis across industries including Agriculture, Consumer Goods, Technology, Automotive, Healthcare, Data Centers, and Logistics. Recognized by top-tier media, our expert team transforms complex market data into actionable strategies, helping clients anticipate trends, seize opportunities, and stay ahead of the competition.

Why Arizton?                                               

100% Customer Satisfaction                                               

24×7 availability – we are always there when you need us                                               

200+ Fortune 500 Companies trust Arizton’s report                                               

80% of our reports are exclusive and first in the industry                                               

100% more data and analysis                                               

1500+ reports published till date                             

Post-Purchase Benefit                                           

1hr of free analyst discussion                                           10% off on customization                        

Contact Us                                   
Mail: enquiry@arizton.com
Contact Us: https://www.arizton.com/contact-us
Website: https://www.arizton.com/
Call: +1 312-680-2940

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/personal-protective-equipment-market-to-reach-usd-34-22-billion-by-2031–3m-dupont-ansell-msa-and-37-key-players-profiled–arizton-302801501.html

Continue Reading

Technology

QC Healthcare Launches as a Healthcare Innovation Holding Company Focused on Telehealth, Clinical Research, Pharmacy Services, Artificial Intelligence, Healthcare Analytics, and Population Health

Published

on

By

New Organization Establishes a Strategic Platform for a Growing Portfolio of Healthcare 
Companies Designed to Improve Access, Outcomes, Innovation, and Healthcare Connectivity Across the United States and Globally

CHARLOTTE, N.C. and ATLANTA, June 16, 2026 /PRNewswire/ — QC Healthcare today announced its official launch as a healthcare innovation holding company focused on building, funding, acquiring, and scaling digital health businesses that improve access to care, advance healthcare delivery, and create measurable improvements in patient outcomes.

Headquartered in Charlotte, North Carolina, with executive leadership and operations spanning Atlanta, Georgia, QC Healthcare has been established as the parent organization for a growing portfolio of healthtech companies operating across telehealth, specialty care, clinical research, pharmacy services, healthcare technology, health AI, healthcare analytics, population health, and healthcare innovation.

The company is led by healthcare executive, entrepreneur, and commercialization leader Eric Doherty, who serves as Founder and Chief Executive Officer of QC Healthcare. Doherty is widely recognized for his work in healthcare commercialization, business transformation, healthcare access initiatives, artificial intelligence in healthcare, population health, specialty pharmacy, and digital health innovation.

“Healthcare is entering one of the most transformational periods in its history,” said Doherty. “The convergence of telehealth, artificial intelligence, clinical research, healthcare analytics, pharmacy services, remote diagnostics, and population health is creating opportunities to fundamentally improve how care is delivered. QC Healthcare was established to bring these capabilities together under one strategic platform capable of creating meaningful improvements in access, outcomes, efficiency, and innovation.”

Building an Integrated Healthcare Ecosystem

Unlike traditional healthcare organizations focused on a single service line, QC Healthcare is a diversified holding company designed to support multiple sectors across the healthcare ecosystem.
The organization’s first operating company is My Pediatric Doctor, a national pediatric telehealth company dedicated to providing families with convenient access to board-certified pediatric healthcare services.

Building on that foundation, QC Healthcare is developing a family of interconnected healthcare brands designed to address patient care needs across multiple populations and clinical specialties. Planned and future healthcare platforms include:

My Adult DoctorMy VA DoctorMy Vet DoctorMy Oncology DoctorAdditional specialty-focused healthcare brands

The company’s vision is to create a unified healthcare ecosystem where patients can access specialized clinical care through technology-enabled care delivery models while benefiting from shared infrastructure, care coordination, healthcare analytics, and AI-driven support tools.

Supporting Veterans and Military Families

Among QC Healthcare’s planned initiatives is a dedicated healthcare platform focused on serving veterans, military families, reservists, National Guard members, active-duty personnel, and retired service members.

The company recognizes the unique healthcare challenges faced by veterans and military families, including continuity of care, chronic disease management, behavioral health support, specialty care access, and healthcare navigation.

QC Healthcare also intends to explore opportunities to support retired military personnel and veterans living internationally. Many veterans choose to reside abroad following military service, often creating challenges related to healthcare access and care coordination. Through telehealth, digital health technologies, and strategic partnerships, the organization hopes to create solutions that improve healthcare accessibility regardless of where veterans and their families reside.

Expanding Specialty-Based Healthcare Access

Beyond primary care and pediatric services, QC Healthcare plans to develop specialty-focused healthcare platforms addressing areas such as oncology, cardiology, chronic disease management, preventive care, women’s health, men’s health, and other high-demand clinical specialties. Technology-enabled specialty care can help reduce barriers to healthcare access while improving patient engagement, continuity of care, and long-term outcomes.

Advancing Animal Health Innovation

QC Healthcare also sees significant opportunities within animal health. Planned initiatives will explore innovative approaches to veterinary telehealth, preventive care, wellness programs, specialist access, rural veterinary support, livestock health initiatives, and technology-enabled animal healthcare services — applying the same innovation principles transforming human healthcare to improve access, efficiency, and outcomes across animal health markets.

Clinical Research, Pharmacy, and Healthcare Innovation

QC Healthcare is evaluating opportunities to establish businesses focused on clinical research, decentralized clinical trials, patient recruitment, healthcare outcomes analysis, and real-world evidence generation. Technology-enabled research models can improve patient participation, accelerate innovation, and create more representative research populations.

QC Healthcare is also exploring future pharmacy ventures that may include specialty pharmacy services, medication adherence programs, patient support services, care coordination, and innovative medication management solutions designed to improve patient outcomes and treatment compliance. These initiatives complement the company’s broader mission of connecting care delivery, research, technology, and patient engagement across the healthcare continuum.

Artificial Intelligence, Data Analytics, and Population Health

A core pillar of QC Healthcare’s strategy involves leveraging health AI and healthcare data to improve decision-making and patient outcomes. Areas of strategic interest include:

Predictive healthcare analyticsPopulation health managementHealthcare intelligence platformsClinical decision supportRemote patient monitoringOutcomes measurementDisease management analyticsCare gap identificationAI-enabled workflow optimizationHealthcare interoperability solutions

“Artificial intelligence should empower healthcare professionals, not replace them,” Doherty said. “The goal is to provide better insights, improve clinical decision-making, strengthen patient engagement, and help health systems operate more effectively.”

Commitment to Rural Health and Underserved Communities

A cornerstone of QC Healthcare’s mission is improving healthcare access for underserved populations. The company intends to pursue partnerships and programs focused on supporting: 

Rural communitiesMedically underserved populationsNative American and Tribal communitiesVeterans and military familiesInternational populations with limited healthcare accessCommunities experiencing provider shortages

Potential initiatives may include telehealth expansion, remote diagnostics, healthcare workforce support, school-based healthcare programs, community partnerships, and advanced connectivity solutions designed to bring healthcare services to regions where access remains limited. QC Healthcare also recognizes the growing role of emerging technologies — including satellite-based connectivity and remote healthcare infrastructure — in addressing healthcare disparities in rural and underserved regions.

National and International Vision

While initially focused on the United States, QC Healthcare has been established with a global vision. The organization plans to explore international opportunities involving telehealth, healthcare technology deployment, clinical research collaborations, healthcare workforce development, healthcare analytics, population health programs, and innovative healthcare delivery models.

The company expects to collaborate with healthcare systems, hospitals, physician groups, employers, life sciences organizations, academic institutions, technology companies, and public-private partnerships that share a commitment to improving healthcare access and outcomes. QC Healthcare also plans to engage with stakeholders involved in healthcare modernization, workforce development, rural health initiatives, and public health efforts — including potential collaborations with the U.S. Department of Health and Human Services (HHS), the U.S. Chamber of Commerce, and strategic healthcare partners.

“Our vision is significantly larger than telehealth alone,” Doherty concluded. “We are building a healthcare platform that connects patients, providers, researchers, healthcare systems, employers, life sciences organizations, government stakeholders, and innovators through integrated healthcare solutions. Whether through virtual care, clinical research, pharmacy services, artificial intelligence, healthcare analytics, specialty care, population health, or future healthcare technologies, our mission is to improve lives and help shape the future of healthcare.”

As QC Healthcare expands its portfolio, the company expects to announce additional operating companies, strategic partnerships, healthcare technology initiatives, acquisitions, research collaborations, and growth investments throughout the coming year.

About QC Healthcare
QC Healthcare is a healthcare innovation holding company headquartered in Charlotte, North Carolina, with executive leadership and operations spanning Atlanta, Georgia. The company focuses on building, funding, acquiring, and scaling healthtech businesses across telehealth, specialty care, clinical research, pharmacy services, artificial intelligence, healthcare analytics, population health, healthcare technology, and digital health. Through its growing portfolio of healthcare companies, QC Healthcare is committed to improving healthcare access, affordability, outcomes, innovation, and connectivity for patients, providers, health systems, employers, researchers, and communities worldwide.

For more information, visit QC Healthcare and My Pediatric Doctor 

For Press Inquiries:  Contact@MyPediatricDoctor.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/qc-healthcare-launches-as-a-healthcare-innovation-holding-company-focused-on-telehealth-clinical-research-pharmacy-services-artificial-intelligence-healthcare-analytics-and-population-health-302800863.html

SOURCE QC Healthcare

Continue Reading

Trending